Home Drugs Buprenorphine Option Did Not Improve Pain, Reduce Opioid Dosage

Buprenorphine Option Did Not Improve Pain, Reduce Opioid Dosage

by Newsroom


When patients were given the option of switching from high-dose opioids to buprenorphine, researchers observed minimal improvements in pain and reductions in opioid use. The data, published in JAMA Internal Medicine, also showed outcomes were similar whether patients switched medications or not.1

“Persons receiving long-term opioid therapy (LTOT) for pain, especially at high doses, typically experience physical dependence. In physical dependence, reducing or discontinuing opioids may cause unpleasant withdrawal symptoms, including increased pain and dysphoria, that can last for weeks, months, or even years,” wrote authors of the study.

The use of…



Source link

You may also like

About Us

Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:

Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC